216 related articles for article (PubMed ID: 30996178)
1. Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease.
Kono M; Sakurai T; Okamoto K; Nagai T; Komeda Y; Kashida H; Minaga K; Kamata K; Takenaka M; Hagiwara S; Watanabe T; Nishida N; Enoki E; Inoue H; Matsumura I; Kudo M
Intern Med; 2019 Jul; 58(14):2029-2033. PubMed ID: 30996178
[TBL] [Abstract][Full Text] [Related]
2. Induction of Complete Remission by Azacitidine in a Patient with Myelodysplastic Syndrome-Associated Inflammatory Bowel Disease.
Kono M; Komeda Y; Sakurai T; Okamoto A; Minaga K; Kamata K; Hagiwara S; Inoue H; Enoki E; Matsumura I; Watanabe T; Kudo M
J Crohns Colitis; 2018 Mar; 12(4):499-502. PubMed ID: 29253109
[TBL] [Abstract][Full Text] [Related]
3. Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease.
Nishioka K; Ogino H; Chinen T; Ihara E; Tanaka Y; Nakamura K; Ogawa Y
J Gastroenterol; 2021 Nov; 56(11):976-987. PubMed ID: 34448069
[TBL] [Abstract][Full Text] [Related]
4. Research progress of Ustekinumab in the treatment of inflammatory bowel disease.
Zhang W; Zhong G; Ren X; Li M
Front Immunol; 2024; 15():1322054. PubMed ID: 38455044
[TBL] [Abstract][Full Text] [Related]
5. Ustekinumab for skin reactions associated with anti-tumor necrosis factor-α agents in patients with inflammatory bowel diseases: A single-center retrospective study.
Ezzedine K; Visseaux L; Cadiot G; Brixi H; Bernard P; Reguiai Z
J Dermatol; 2019 Apr; 46(4):322-327. PubMed ID: 30816581
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab.
Saleh A; Stading R; Miroballi N; Glassner K; Abraham BP
J Dig Dis; 2024 Apr; 25(4):214-221. PubMed ID: 38587053
[TBL] [Abstract][Full Text] [Related]
7. Ustekinumab for children and adolescents with inflammatory bowel disease at a tertiary children's hospital in Japan.
Takeuchi I; Arai K; Kyodo R; Sato T; Tokita K; Hirano Y; Shimizu H
J Gastroenterol Hepatol; 2021 Jan; 36(1):125-130. PubMed ID: 32497325
[TBL] [Abstract][Full Text] [Related]
8. Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet's-like disease accompanied with myelodysplastic syndrome involving trisomy 8.
Tanaka N; Sakuraba H; Hiraga H; Mayama K; Kikuchi H; Kishida D; Akemoto Y; Hasui K; Ota S; Watanabe R; Murai Y; Maeda T; Kamata K; Tatsuta T; Sawaya M; Chinda D; Mikami T; Yamagata K; Ishiguro Y; Tanaka M; Fukuda S
Immunol Med; 2019 Sep; 42(3):135-141. PubMed ID: 31707933
[TBL] [Abstract][Full Text] [Related]
9. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature.
Hebbar M; Kozlowski D; Wattel E; Mastrini S; Diévart M; Duclos B; Bonaz B; d'Almagne H; Belaiche J; Colombel JF; Fenaux P
Leukemia; 1997 Dec; 11(12):2188-91. PubMed ID: 9447839
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease.
Deepak P; Sandborn WJ
Gastroenterol Clin North Am; 2017 Sep; 46(3):603-626. PubMed ID: 28838418
[TBL] [Abstract][Full Text] [Related]
12. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.
Barré A; Colombel JF; Ungaro R
Aliment Pharmacol Ther; 2018 Apr; 47(7):896-905. PubMed ID: 29430672
[TBL] [Abstract][Full Text] [Related]
13. A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases.
Verstockt B; Deleenheer B; Van Assche G; Vermeire S; Ferrante M
Expert Opin Drug Saf; 2017 Jul; 16(7):809-821. PubMed ID: 28573876
[TBL] [Abstract][Full Text] [Related]
14. Intestinal ulcers in a patient with myelodysplastic syndrome: a case report.
Zhang X; Jin M; Shen Z; Wan X; Li L; Zhang Y; Zhou X; Mei C; Tong H; Yu C
BMC Gastroenterol; 2021 Oct; 21(1):372. PubMed ID: 34635067
[TBL] [Abstract][Full Text] [Related]
15. [A case of intestinal Behçet's disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the perforation of ileum ulcer].
Tanaka E; Nishinarita M; Uesato M; Kamatani N
Ryumachi; 2000 Aug; 40(4):711-8. PubMed ID: 11021176
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).
Macaluso FS; Fries W; Viola A; Costantino G; Muscianisi M; Cappello M; Guida L; Giuffrida E; Magnano A; Pluchino D; Ferracane C; Magrì G; Di Mitri R; Mocciaro F; Privitera AC; Camilleri S; Garufi S; Renna S; Casà A; Scrivo B; Ventimiglia M; Orlando A
Expert Opin Biol Ther; 2020 Nov; 20(11):1381-1384. PubMed ID: 32981373
[TBL] [Abstract][Full Text] [Related]
17. The first case report of de novo Crohn's disease after heart transplantation successfully treated with ustekinumab.
Okamura S; Bujo C; Amiya E; Kurokawa K; Hatano M; Ishida J; Tsuji M; Ihara S; Murakami K; Shiomi C; Hayakawa Y; Fujishiro M; Ono M; Komuro I
J Cardiol Cases; 2024 Apr; 29(4):174-177. PubMed ID: 38646076
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inflammatory bowel disease and myelodysplastic syndromes.
Harewood GC; Loftus EV; Tefferi A; Tremaine WJ; Sandborn WJ
Inflamm Bowel Dis; 1999 May; 5(2):98-103. PubMed ID: 10338378
[TBL] [Abstract][Full Text] [Related]
19. [Ustekinumab - Current position].
Siegmund B; Högenauer C; Novacek G; Petritsch W; Reinisch W; Schoepfer A; Schreiber S; Vavricka S; Bokemeyer B;
Z Gastroenterol; 2018 Sep; 56(9):1077-1086. PubMed ID: 30103222
[TBL] [Abstract][Full Text] [Related]
20. Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study.
Avni-Biron I; Mishael T; Zittan E; Livne-Margolin M; Zinger A; Tzadok R; Goldenberg R; Kopylov U; Ron Y; Hadar E; Helman S; Granovsky SG; Ollech JE; Arazi A; Farkash R; Pauker MH; Yanai H; Dotan I; Shitrit AB
Aliment Pharmacol Ther; 2022 Nov; 56(9):1361-1369. PubMed ID: 36168705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
